| Primary |
| Hypersensitivity |
17.7% |
| Product Used For Unknown Indication |
11.5% |
| Seasonal Allergy |
11.5% |
| Nasal Congestion |
8.0% |
| Vitamin Supplementation |
8.0% |
| Asthma |
5.3% |
| Drug Use For Unknown Indication |
5.3% |
| Hypertension |
4.4% |
| Prophylaxis |
4.4% |
| Glaucoma |
3.5% |
| Sinus Congestion |
3.5% |
| Multiple Allergies |
2.7% |
| Off Label Use |
2.7% |
| Atrial Fibrillation |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Diabetes Mellitus |
1.8% |
| Eye Allergy |
1.8% |
| Rhinitis Allergic |
1.8% |
| Rhinorrhoea |
1.8% |
| Anxiety |
0.9% |
|
| Epistaxis |
11.1% |
| Drug Ineffective |
8.9% |
| Nasal Discomfort |
8.9% |
| Blood Pressure Increased |
6.7% |
| Dry Eye |
6.7% |
| Sinusitis |
6.7% |
| Dizziness |
4.4% |
| Drug Effect Decreased |
4.4% |
| Heart Rate Increased |
4.4% |
| Incorrect Route Of Drug Administration |
4.4% |
| Insomnia |
4.4% |
| Nasal Oedema |
4.4% |
| Nervousness |
4.4% |
| Rhinorrhoea |
4.4% |
| Sneezing |
4.4% |
| Abdominal Pain Upper |
2.2% |
| Chest Discomfort |
2.2% |
| Condition Aggravated |
2.2% |
| Deafness Neurosensory |
2.2% |
| Death |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
18.5% |
| Asthma |
9.8% |
| Drug Use For Unknown Indication |
8.7% |
| Sinus Congestion |
8.7% |
| Seasonal Allergy |
7.6% |
| Hypersensitivity |
5.4% |
| Drug Exposure During Pregnancy |
4.3% |
| Eye Pruritus |
4.3% |
| Hypertension |
4.3% |
| Nasal Congestion |
4.3% |
| Eczema |
3.3% |
| Headache |
3.3% |
| Arthralgia |
2.2% |
| Cerebral Infarction |
2.2% |
| Cholelithiasis |
2.2% |
| Chronic Sinusitis |
2.2% |
| Dry Throat |
2.2% |
| Hyperlipidaemia |
2.2% |
| Lacrimation Increased |
2.2% |
| Off Label Use |
2.2% |
|
| Drug Ineffective |
11.8% |
| Drug Hypersensitivity |
8.8% |
| Ear Discomfort |
8.8% |
| Somnolence |
8.8% |
| Premature Baby |
5.9% |
| Rash Pruritic |
5.9% |
| Stevens-johnson Syndrome |
5.9% |
| Swelling Face |
5.9% |
| Tubulointerstitial Nephritis |
5.9% |
| Chest Discomfort |
2.9% |
| Death |
2.9% |
| Drug Eruption |
2.9% |
| Dysgeusia |
2.9% |
| Epistaxis |
2.9% |
| Exposure During Pregnancy |
2.9% |
| Feeling Abnormal |
2.9% |
| Haemangioma |
2.9% |
| Haematochezia |
2.9% |
| Hypersensitivity |
2.9% |
| Hypotonia |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.5% |
| Drug Use For Unknown Indication |
23.0% |
| Asthma |
12.5% |
| Hiv Infection |
6.6% |
| Folliculitis |
4.3% |
| Seasonal Allergy |
3.3% |
| Hypersensitivity |
2.6% |
| Rheumatoid Arthritis |
2.5% |
| Depression |
2.1% |
| Prophylaxis |
2.1% |
| Mastocytosis |
1.8% |
| Pain |
1.8% |
| Antifungal Prophylaxis |
1.7% |
| Diffuse Large B-cell Lymphoma |
1.7% |
| Anxiety |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Hypertension |
1.3% |
| Complex Regional Pain Syndrome |
1.1% |
| Candidiasis |
1.1% |
| Blood Pressure |
1.0% |
|
| Pain In Jaw |
9.8% |
| Talipes |
7.6% |
| Hyperglycaemia |
6.5% |
| Ivth Nerve Paresis |
6.5% |
| Pyrexia |
6.5% |
| Vomiting |
6.5% |
| Death |
5.4% |
| Suicidal Ideation |
5.4% |
| Urticaria |
5.4% |
| Adrenal Insufficiency |
4.3% |
| International Normalised Ratio Increased |
4.3% |
| Renal Failure |
4.3% |
| Sudden Cardiac Death |
4.3% |
| Drug Exposure During Pregnancy |
3.3% |
| Gastrointestinal Haemorrhage |
3.3% |
| Hypersensitivity |
3.3% |
| Nausea |
3.3% |
| Nightmare |
3.3% |
| Pemphigus |
3.3% |
| Sepsis |
3.3% |
|
